Director Declaration
Updated : 12:00
This regulatory news is for Private Investors only
RNS Number : 9084H
Genus PLC
21 November 2018
21 November 2018
Genus plc
Director Declaration
Genus plc (LSE: GNS) today announces that Lykele van der Broek, Non-Executive Director, has been appointed as a Non-Executive Director and Chairman of the Supervisory Board of Aspen Oss B.V., a manufacturer of active pharmaceutical ingredients in the human healthcare sector, which is a wholly owned subsidiary of Aspen Pharmacare Holdings Ltd listed on the Johannesburg Stock Exchange, with effect from 21 November 2018.
This announcement is being made pursuant to 9.6.14 of the Listing Rules.
For further information please contact:
Genus:
Dan Hartley, Group General Counsel & Company Secretary Tel: +44 (0)1256 347100
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.